“Our research highlights the safety and the potential for GLP-1 receptor agonists [like semaglutide] to reduce the risk of acute pancreatitis recurrence in individuals with obesity and type 2 diabetes, challenging previous concerns and offering new hope for effective disease management,” Nassar...
The meds also stimulate the endothelium (the lining of the blood vessels) to produce nitric oxide, which is crucial for healthy blood vessel function. It also lowers the levels of oxidative stress that can lead to cell and tissue damage, according to some research. Another study fo...
National Library of Medicine. Semaglutide injection. Revised April 20, 2024. Accessed June 4, 2024.https://medlineplus.gov/druginfo/meds/a618008.html US Food and Drug Administration. FDA approves new drug treatment for chronic weight management, first since 2014. June 4, 2021. Accessed June ...